Gene · 710
Papers4,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,381 to 1,400 of 4,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Assessment of disease activity and quality of life in patients with recurrent bradykinin-mediated versus mast cell-mediated angioedema. | World Allergy Organ J | 2021 | 34221217 | PubTator, text mining | PubMed |
| Limb ischemia in patients with COVID-19. | J Vasc Bras | 2021 | 34211543 | PubTator, text mining | PubMed |
| CFH and CFHR Copy Number Variations in C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis. | Front Genet | 2021 | 34211499 | PubTator, text mining | PubMed |
| IGFBP2 Is a Potential Master Regulator Driving the Dysregulated Gene Network Responsible for Short Survival in Glioblastoma Multiforme. | Front Genet | 2021 | 34211498 | PubTator, text mining | PubMed |
| Display of the human mucinome with defined O-glycans by gene engineered cells. | Nat Commun | 2021 | 34210959 | PubTator, text mining | PubMed |
| Gene Expression Profiling Reveals New Pathways and Genes Associated with Visna/Maedi Viral Disease. | Animals (Basel) | 2021 | 34203742 | PubTator, text mining | PubMed |
| Effect of Precursor Deficiency Induced Ca/P Ratio on Antibacterial and Osteoblast Adhesion Properties of Ag-Incorporated Hydroxyapatite: Reducing Ag Toxicity. | Materials (Basel) | 2021 | 34201287 | PubTator, text mining | PubMed |
| Gut Serpinome: Emerging Evidence in IBD. | Int J Mol Sci | 2021 | 34200095 | PubTator, text mining | PubMed |
| The Serpin Superfamily and Their Role in the Regulation and Dysfunction of Serine Protease Activity in COPD and Other Chronic Lung Diseases. | Int J Mol Sci | 2021 | 34198546 | PubTator, text mining | PubMed |
| Clinical manifestations of hereditary angioedema and a systematic review of treatment options. | Laryngoscope Investig Otolaryngol | 2021 | 34195359 | PubTator, text mining | PubMed |
| The Evaluation and Validation of Blood-Derived Novel Biomarkers for Precise and Rapid Diagnosis of Tuberculosis in Areas With High-TB Burden. | Front Microbiol | 2021 | 34194403 | PubTator, text mining | PubMed |
| Complement as driver of systemic inflammation and organ failure in trauma, burn, and sepsis. | Semin Immunopathol | 2021 | 34191093 | PubTator, text mining | PubMed |
| Halting targeted and collateral damage to red blood cells by the complement system. | Semin Immunopathol | 2021 | 34191092 | PubTator, text mining | PubMed |
| Psychosocial burden of type 1 and 2 hereditary angioedema: a single-center Canadian cohort study. | Allergy Asthma Clin Immunol | 2021 | 34187550 | PubTator, text mining | PubMed |
| The plasma peptides of Alzheimer's disease. | Clin Proteomics | 2021 | 34182925 | PubTator, text mining | PubMed |
| Potential therapeutic target genes for systemic lupus erythematosus: a bioinformatics analysis. | Bioengineered | 2021 | 34180358 | PubTator, text mining | PubMed |
| Autoimmune diseases - New insights into a troublesome field. | J Transl Autoimmun | 2021 | 34179743 | PubTator, text mining | PubMed |
| Identification of Dysregulated Complement Activation Pathways Driven by N-Glycosylation Alterations in T2D Patients. | Front Chem | 2021 | 34178943 | PubTator, text mining | PubMed |
Letting the patients speak: an in-depth, qualitative research-based investigation of factors relevant to health-related quality of life in real-world patients with hereditary angioedema using subcutaneous C1 inhibitor replacement therapy. | Allergy Asthma Clin Immunol | 2021 | 34176500 | PubTator, text mining | PubMed |
| Effectiveness of lanadelumab for preventing hereditary angioedema attacks: Subgroup analyses from the HELP study. | Clin Exp Allergy | 2021 | 34166549 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/papers?page=70